Liposomal nanomedicines
The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Liposomal nanoparticles (LNs) encapsulating therapeutic agents, or liposomal nanomedicines, represent an advanced class of drug delivery systems, with several formulations presently on the market and many more in clinical trials. Over the past 20 years, a variety of techniques have been developed for encapsulating both conventional drugs (such as anticancer drugs and antibiotics) and the new genetic drugs (plasmid DNA containing therapeutic genes, antisense oligonucleotides and small interfering RNA) within LNs. If the LNs possess certain properties, they tend to accumulate at sites of disease, such as tumours, where the endothelial layer is 'leaky' and allows extravasation of particles with small diameters. These properties include a diameter centred on 100 nm, a high drug-to-lipid ratio, excellent retention of the encapsulated drug, and a long (> 6 h) circulation lifetime. These properties permit the LNs to protect their contents during circulation, prevent contact with healthy tissues, and accumulate at sites of disease. The authors discuss recent advances in this field involving conventional anticancer drugs, as well as applications involving gene delivery, stimulation of the immune system and silencing of unwanted gene expression. Liposomal nanomedicines have the potential to offer new treatments in such areas as cancer therapy, vaccine development and cholesterol management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 6×
“LNs are a versatile class of drug carrier particles capable of delivering conventional and genetic drugs to diseased tissue that exhibits leaky vasculature (tumours and sites of inflammation) and, therefore, allows exploitation of the EPR effect.”
BackgroundInfluentialA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 3×
“The strong response to bacterial DNA results from the recognition of unmethylated CpG dinucleotides in a particular base context – mammalian DNA has a lower frequency of CpG sequences and they are usually methylated [99] .”
BackgroundRecognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“The possibility of using liposomes as carriers of therapeutic agents was recognised soon after their discovery in the 1960s [20,21] , even though it took many years before the appropriate technologies were in place [5,22-24] .”
BackgroundDrug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · cited 1×
“Over the past two decades, liposomes have evolved from simple model membrane systems into sophisticated carriers for a wide variety of therapeutic agents [1] .”
BackgroundSelf-citationSpecies-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495 · cited 6×
“LNs are a versatile class of drug carrier particles capable of delivering conventional and genetic drugs to diseased tissue that exhibits leaky vasculature (tumours and sites of inflammation) and, therefore, allows exploitation of the EPR effect.”
BackgroundInfluentialVesicles of variable sizes produced by a rapid extrusion procedure
Mayer, L. D., Hope, M. J., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90302-0 · Cited by 1,691
Self-citationHuman TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J., Sato, A., Akira, S., Medzhitov, R., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,198
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934 · cited 2×
“However, high levels of encapsulation of ciprofloxacin can be achieved using an alternate ∆ pH-loading method that is based on transmembrane gradients of ammonium sulfate [46,47] (see Figure 3 ).”
BackgroundMethodMaeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M.-D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., & Raz, E. (1997) · Nature Medicine · doi:10.1038/nm0897-849 · Cited by 908
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
DNA-based therapeutics and DNA delivery systems: A comprehensive review
Patil, S. D., Rhodes, D. G., & Burgess, D. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070109 · Cited by 630
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
Heyes, J., Palmer, L., Bremner, K., & MacLachlan, I. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.014 · Cited by 572
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Membrane models with phospholipids
Bangham, A. D. (1968) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(68)90019-9 · Cited by 544
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454
Self-citationLong-circulating (sterically stabilized) liposomes for targeted drug delivery
Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 445
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438
Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 418
Drummond, D. C., Noble, C. O., Guo, Z., Hong, K., Park, J. W., & Kirpotin, D. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4007 · Cited by 380
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
Mayer, L. D., Bally, M. B., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90105-7 · Cited by 379
Self-citationThe Liposomal Formulation of Doxorubicin
Abraham, S. A., Waterhouse, D. N., Mayer, L. D., Cullis, P. R., Madden, T. D., & Bally, M. B. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)91004-5 · Cited by 355
Self-citationLiposomal encapsulated anti-cancer drugs
Hofheinz, R.-D., Gnad-Vogt, S. U., Beyer, U., & Hochhaus, A. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000167902.53039.5a · Cited by 355
Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Bally, M. B., & Janoff, A. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0118 · Cited by 331
Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2291 · Cited by 314
A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA
Jeffs, L. B., Palmer, L. R., Ambegia, E. G., Giesbrecht, C., Ewanick, S., & MacLachlan, I. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1873-z · Cited by 307 · cited 1×
“An important step forward was, thus, realised with the development of a simple and fully scalable method for the formation of SPLPs by spontaneous vesicle formation [82] .”
MethodStabilized plasmid-lipid particles: construction and characterization
Wheeler, J. J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R. W., Zhang, Y. P., Hope, M. J., Scherrer, P., & Cullis, P. R. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300821 · Cited by 299
Self-citationGelation of liposome interior A novel method for drug encapsulation
Lasic, D. D., Frederik, P. M., Stuart, M. C. A., Barenholz, Y., & McIntosh, T. J. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80947-f · Cited by 261
Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient
Li, X., Hirsh, D. J., Cabral-Lilly, D., Zirkel, A., Gruner, S. M., Janoff, A. S., & Perkins, W. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00175-8 · Cited by 259
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey
Madden, T. D., Harrigan, P. R., Tai, L. C. L., Bally, M. B., Mayer, L. D., Redelmeier, T. E., Loughrey, H. C., Tilcock, C. P. S., Reinish, L. W., & Cullis, P. R. (1990) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(90)90131-a · Cited by 255
Self-citationGeisbert, T. W., Hensley, L. E., Kagan, E., Yu, E. Z., Geisbert, J. B., Daddario‐DiCaprio, K., Fritz, E. A., Jahrling, P. B., McClintock, K., Phelps, J. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/504267 · Cited by 254
Ligand-Targeted Liposomes for Cancer Treatment
Sapra, P., Tyagi, P., & Allen, T. (2005) · Current Drug Delivery · doi:10.2174/156720105774370159 · Cited by 246
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients
Mayer, L. D., Tai, L. C. L., Bally, M. B., Mitilenes, G. N., Ginsberg, R. S., & Cullis, P. R. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90091-2 · Cited by 245
Self-citationWebb, M., Harasym, T., Masin, D., Bally, M., & Mayer, L. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.430 · Cited by 243
Pastorino, F., Brignole, C., Di Paolo, D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 232
Maurer, N., Wong, K. F., Stark, H., Louie, L., McIntosh, D., Wong, T., Scherrer, P., Semple, S. C., & Cullis, P. R. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76202-9 · Cited by 232
Self-citationUnusual lipid structures selectively reduce the toxicity of amphotericin B.
Janoff, A. S., Boni, L. T., Popescu, M. C., Minchey, S. R., Cullis, P. R., Madden, T. D., Taraschi, T., Gruner, S. M., Shyamsunder, E., & Tate, M. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6122 · Cited by 223
Self-citationCullis, P. R., Hope, M. J., Bally, M. B., Madden, T. D., Mayer, L. D., & Fenske, D. B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(97)00006-3 · Cited by 212
Self-citationTransmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.
Lasic, D. D., Čeh, B., Stuart, M. C. A., Guo, L., Frederik, P. M., & Barenholz, Y. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00159-z · Cited by 209
Ambegia, E., Ansell, S., Cullis, P., Heyes, J., Palmer, L., & MacLachlan, I. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.001 · Cited by 202
Self-citationZhigaltsev, I. V., Maurer, N., Akhong, Q.-F., Leone, R., Leng, E., Wang, J., Semple, S. C., & Cullis, P. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.010 · Cited by 186
Self-citationGursel, I., Gursel, M., Ishii, K. J., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3324 · Cited by 182
Johnston, M., Semple, S. C., Klimuk, S. K., Edwards, K., Eisenhardt, M. L., Leng, E. C., Karlsson, G., Yanko, D., & Cullis, P. R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.01.009 · Cited by 172
Self-citationFormation of transition metal–doxorubicin complexes inside liposomes
Abraham, S. A., Edwards, K., Karlsson, G., MacIntosh, S., Mayer, L. D., McKenzie, C., & Bally, M. B. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00507-2 · Cited by 168
Harrigan, P. R., Wong, K. F., Redelmeier, T. E., Wheeler, J. J., & Cullis, P. R. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90218-o · Cited by 168
Self-citationZamboni, W. C., Gervais, A. C., Egorin, M. J., Schellens, J. H. M., Zuhowski, E. G., Pluim, D., Joseph, E., Hamburger, D. R., Working, P. K., Colbern, G., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0719-4 · Cited by 165
Pulmonary delivery of insulin by liposomal carriers
Huang, Y.-Y., & Wang, C.-H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.014 · Cited by 164
Klinman, D. M., Conover, J., & Coban, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5658-5663.1999 · Cited by 163
Surrogate cells or trojan horses. The discovery of liposomes
Bangham, A. D. (1995) · BioEssays · doi:10.1002/bies.950171213 · Cited by 151
White, S. C., Lorigan, P., Margison, G. P., Margison, J. M., Martin, F., Thatcher, N., Anderson, H., & Ranson, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603345 · Cited by 151
Stabilized plasmid-lipid particles for systemic gene therapy
Tam, P., Monck, M. A., Lee, D., Ludkovski, O., Leng, E. C., Clow, K. A., Stark, H., Scherrer, P., Graham, R. W., & Cullis, P. R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301308 · Cited by 150
Self-citationSarris, A. H., Hagemeister, F. B., Romaguera, J. E., Rodríguez, M., McLaughlin, P. J., Tsimberidou, A. M., Medeiros, L. J., Samuels, B. I., Pate, O., Oholendt, M. S., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008348010437 · Cited by 143
de Jong, S. D., Chikh, G., Sekirov, L., Raney, S. G., Semple, S. C., Klimuk, S. K., Yuan, N., Hope, M., Cullis, P. R., & Tam, Y. K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0276-x · Cited by 138
Self-citationA phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M. E., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., & Herbst, R. S. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 136
Tardi, P. G., Gallagher, R. C., Johnstone, S. A., Harasym, N. L., Webb, M. S., Bally, M. B., & Mayer, L. D. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.014 · Cited by 134
Johnston, M., Semple, S. C., Klimuk, S. K., Ansell, S., Maurer, N., & Cullis, P. R. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.019 · Cited by 133
Self-citationChiu, G. N. C., Abraham, S. A., Ickenstein, L. M., Ng, R., Karlsson, G., Edwards, K., Wasan, E. K., & Bally, M. B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.009 · Cited by 130
Bacterial DNA as immune cell activator
Lipford, G. B. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01408-5 · Cited by 121
Maurer, N., Wong, K. F., Hope, M. J., & Cullis, P. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00125-4 · Cited by 118
Self-citationRNA interference and innate immunity
Sioud, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.006 · Cited by 117
Sapra, P., Moase, E. H., Ma, J., & Allen, T. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0041 · Cited by 114
An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes
Abraham, S. A., Edwards, K., Karlsson, G., Hudon, N. J., Mayer, L. D., & Bally, M. B. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.017 · Cited by 112
Abraham, S. A., McKenzie, C., Masin, D., Ng, R., Harasym, T. O., Mayer, L. D., & Bally, M. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1131-03 · Cited by 111
Zhang, Y. P., Sekirov, L., Saravolac, E. G., Wheeler, J. J., Tardi, P. G., Clow, K. A., Leng, E. C., Sun, R. R., Cullis, P. R., & Scherrer, P. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300965 · Cited by 108
Self-citationSemple, S. C., Leone, R., Wang, J., Leng, E. C., Klimuk, S. K., Eisenhardt, M. L., Yuan, Z.-N., Edwards, K., Maurer, N., Hope, M. J., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20332 · Cited by 101
Self-citationMaurer‐Spurej, E., Wong, K. F., Maurer, N., Fenske, D. B., & Cullis, P. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00204-1 · Cited by 101
Self-citationLoading of doxorubicin into liposomes by forming Mn2+-drug complexes
Cheung, B. C. L., Sun, T. H. T., Leenhouts, J. M., & Cullis, P. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00168-0 · Cited by 96
Self-citationMui, B., Raney, S. G., Semple, S. C., & Hope, M. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29491-x · Cited by 88
Mayer, L. D., Nayar, R., Thies, R. L., Boman, N. L., Cullis, P. R., & Bally, M. B. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686017 · Cited by 87
Self-citationEntrapment of Small Molecules and Nucleic Acid–Based Drugs in Liposomes
Fenske, D. B., & Cullis, P. R. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91001-x · Cited by 85
Self-citationWebb, M. S., Boman, N. L., Wiseman, D. J., Saxon, D., Sutton, K., Wong, K. F., Logan, P., & Hope, M. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.45 · Cited by 85
RNA interference: Implications for cancer treatment
Masiero, M., Nardo, G., Indraccolo, S., & Favaro, E. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.12.004 · Cited by 84
Kirschning, C. J., & Bauer, S. (2001) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00128 · Cited by 81
Optimization of the retention properties of vincristine in liposomal systems
Boman, N. L., Mayer, L. D., & Cullis, P. R. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90256-y · Cited by 80
Self-citationLipid Encapsulation Enables the Effective Systemic Delivery of Polyplex Plasmid DNA
Heyes, J., Palmer, L., Chan, K., Giesbrecht, C., Jeffs, L., & MacLachlan, I. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300101 · Cited by 78
Fenske, D. B., Wong, K. F., Maurer, E., Maurer, N., Leenhouts, J. M., Boman, N., Amankwa, L., & Cullis, P. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00166-7 · Cited by 75
Self-citationLiposomes: Realizing Their Promise
Bangham, A. D. (1992) · Hospital Practice · doi:10.1080/21548331.1992.11705537 · Cited by 75
[3] Stabilized plasmid-lipid particles: A systemic gene therapy vector
Fenske, D. B., MacLachlan, I., & Cullis, P. R. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)46048-x · Cited by 72
Self-citationCopper–topotecan complexation mediates drug accumulation into liposomes
Taggar, A. S., Alnajim, J., Anantha, M., Thomas, A. M., Webb, M. S., Ramsay, E., & Bally, M. B. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.019 · Cited by 72
Wilson, K. D., Raney, S. G., Sekirov, L., Chikh, G., deJong, S. D., Cullis, P. R., & Tam, Y. K. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.04.002 · Cited by 72
Self-citationZhigaltsev, I. V., Maurer, N., Edwards, K., Karlsson, G., & Cullis, P. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.011 · Cited by 66
Self-citationCharacterization and Modulation of Immune Stimulation by Modified Oligonucleotides
Boggs, R. T., McGraw, K. R., Condon, T. F., Flournoy, S., Villiet, P., Bennett, C. F., & Monia, B. P. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.461 · Cited by 62
Highly Immunostimulatory CpG-Free Oligodeoxynucleotides for Activation of Human Leukocytes
Vollmer, J., Janosch, A., Laucht, M., Ballas, Z. K., Schetter, C., & Krieg, A. Μ. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760220761 · Cited by 62
Allen, T. M., Sapra, P., Moase, E. H., Moreira, J. N., & Iden, D. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004771 · Cited by 58
Bacterial DNA as an Evolutionary Conserved Ligand Signalling Danger of Infection to Immune Cells
Heeg, K. M., Sparwasser, T. D., Lipford, G. B., Häcker, H., Zimmermann, S., & Wagner, H. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01691128 · Cited by 49
Transfection properties of stabilized plasmid–lipid particles containing cationic PEG lipids
Palmer, L., Chen, T., Lam, A. M. I., Fenske, D. B., Wong, K. F., MacLachlan, I., & Cullis, P. R. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00058-0 · Cited by 45
Self-citationSphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug
Boehlke, L., & Winter, J. N. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.4.409 · Cited by 35
Fenske, D. B., Palmer, L., Chen, T., Wong, K. F., & Cullis, P. R. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00327-3 · Cited by 33
Self-citationCheng, W., Das, D., Suresh, M. R., & Allen, T. M. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.004 · Cited by 32
Madden, T. D., Janoff, A. S., & Cullis, P. R. (1990) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(90)90114-7 · Cited by 30
Self-citationRNA interference as a novel and powerful tool in immunopharmacological research
Kong, Y., Ruan, L., Ma, L., Cui, Y., Wang, J. M., & Le, Y. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2006.12.011 · Cited by 23
Finn, J. D., Lee, A., MacLachlan, I., & Cullis, P. R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302172 · Cited by 22
Self-citationHigh Efficiency Entrapment of Antisense Oligonucleotides in Liposomes
Stuart, D. D., Semple, S. C., & Allen, T. M. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)87011-3 · Cited by 20
Wheeler, J. J., Veiro, J. A., & Cullis, P. R. (1994) · Molecular Membrane Biology · doi:10.3109/09687689409162233 · Cited by 17
Self-citation
Cited by
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Exosomes: Therapy delivery tools and biomarkers of diseases
Barile, L., & Vassalli, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.020 · Cited by 1,038
Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui, W., Arnold, R. D., & Cummings, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010385 · Cited by 581
Metadata
- Authors
- Fenske, D. B., & Cullis, P. R.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2007-12-21
- Volume
- 5
- Issue
- 1
- Pages
- 25-44
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W4251414021
- Cited by
- 253
- References
- 102
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.